Dr Huajie (Lily) Jin
Senior Lecturer in Health Economics
- Deputy Head of King’s Health Economics
Dr. Huajie Jin (Lily) is a Senior Lecturer and Deputy Head at King’s Health Economics (KHE), located at the Institute of Psychiatry, Psychology, and Neuroscience at King’s College London (KCL). She also holds an Honorary Associate Professorship at the Division of Psychiatry, University College London (UCL), and at the Health Technology Assessment Research Department of the Shanghai Health Development Research Centre.
Lily has intensive research experience in health economic evaluation, including model-based and/or trial-based economic evaluation, cost-of-illness study and budget-impact analysis. She is particularly interested in the development and reuse of whole disease models. She has been working on a wide range of different disease areas, including mental health disorders, cancers, kidney diseases, infectious diseases, and orthodontics.
Lily welcomes PhD applications about applied and/or methodological research related to health economic evaluation.
Lily gained BSc in Medicine from Southeast University (PRC) in 2008 and completed MSc in International Health Policy (health Economics stream) from LSE in 2009. Following the completion of MSc, Lily worked on the National Institute for Health and Care Excellence (NICE) clinical guidelines for three years. During this period, Lily was the principal health economist of three NICE clinical guidelines and three NICE Medtech innovation briefings (MIBs).
In 2013 Lily joined KCL as Senior Health Economist, whilst working she completed her part time PhD in 2019, which aims to build an individual patient level whole disease model covering the entire care pathway for schizophrenia service in the UK. Her PhD study was awarded “PhD of the year” in Health Service and Population Research Department. Lily was appointed as Senior Lecturer in Health Economics in 2021.
Selected current projects
Lily is currently leading the health economic analysis for the following projects:
· PROSPECTS (https://medphys.royalsurrey.nhs.uk/prospects/). A multi-centre clinical trial which aims to compare the cost-effectiveness of breast cancer screening using DBT + 2DDM or S2D with screening using 2DDM, based on data for 100,000 women aged 50-70 years who are attending routine breast screening.
· PROTID (https://www.protid-africa.com/project/). A multinational clinical trial which will randomise 3,000 people with diabetes and latent tuberculosis infection in Tanzania and Uganda to a 12-week course of rifapentine and isoniazid preventive therapy or placebo.
· STARRT-AKI (https://www.thebottomline.org.uk/summaries/icm/starrt-aki/). A multinational clinical trial which aims to compare the cost-effectiveness of accelerated initiation of renal replacement therapy compared to standard initiation in 2,927 critically ill patients with severe acute kidney injury.
· YouScreen (https://www.eastlondonhcp.nhs.uk/aboutus/youscreen.htm). A 3-year pragmatic implementation feasibility clinical trial which aims to compare the cost-effectiveness of vaginal self-sampling with the standard call/recall system based on data for 31,000 women and people with a cervix in north and east London.
Lily is also involved in early economic modelling for new health technologies under development.
- Health Technology Assessment
- Cost-effectiveness/utility analysis
- Budget impact analysis
- Cost-of-illness study
- Health economic modelling (e.g., decision tree, Markov model, and discrete event simulation)
- Whole disease modelling
- Trial-based economic evaluation
- Real-world evidence
Current PhD students
- Primary PhD supervisor – Mr. Darren Lui, KCL (2021-Present)
PhD Title: Pharmacoeconomic Considerations for Early-Stage Drug R&D Pharmaceutical Management Decision Making
With: Dr. Nichola Naylor (UK Health Security Agency and LSHTM)
- Primary PhD supervisor – Mr. Nicolás Jaña Valencia, KCL (2021-Present)
PhD Title: Cost-effectiveness analysis of a value-based Integrated Practice Unit for adults with cardiometabolic diseases at risk of developing or progressing to a more severe stage of chronic kidney disease in Chile
With: Dr. Salma Ayis (KCL) and Dr. Magdalena Walbaum (LSE)
- Primary PhD supervisor – Ms. Xiaoyu Zhang, KCL (2021-Present)
PhD Title: Cost of illness study of inflammatory arthritis patients with mental health disorders in the UK
With: Dr. Sam Norton (KCL) and Dr. James Galloway (KCL)
- Co-Primary PhD supervisor – Mr. Zhengwei Wang, KCL (2021-Present)
PhD Title: Cost-effectiveness of cognitive behavioural therapy for children and young people with post-traumatic stress disorder in the UK
Supervision with: Prof. Sarah Byford (KCL)
Expertise and Public Engagement
Selection of recent public presentations